Genetic Variants and Haplotypes in the IL10 Gene and Their Association with Opportunistic Infections among HIV-Infected Patients in Korea in the Era of Highly Active Antiretroviral Therapy
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Background: Genetic variants and haplotypes of the interleukin-10 (IL10) gene have been shown to affect clinical outcomes, including the incidence of opportunistic infections (OIs), in HIV-infected patients. This study investigated the effect of IL10 gene variants on susceptibility to OIs in HIV-infected Korean patients in the era of highly active antiretroviral therapy (HAART). Methods: Eighty-five HIV-infected patients receiving HAART were enrolled in the study. OIs were diagnosed based on the published criteria of the Korean Society for AIDS. Three promoter SNPs and four haplotype-tagging SNPs (htSNPs) of IL10 were selected and genotyped. The haplotypes were reconstructed according to the genotyping data and linkage disequilibrium (LD) status of these SNPs. Results: During the study, 38 OIs developed in 23 of the 85 patients (27.1%), at a rate of 1.7 episodes/ patient. Carrying the minor alleles at the rs1518111, rs3024490, and rs1800871 SNPs had a protective effect against OIs (adjusted P=0.035). Among the seven assessed variants, only three possible haplotypes were observed. The second most common haplotype, which was composed of the rs1518111 minor allele and the rs3021094 major allele showed a protective effect against OIs (P=0.0153). Conclusion: This study demonstrated that some IL10 genetic variants and haplotypes are associated with protective effects against OIs in the era of HAART. These data suggest the potential of two htSNPs, rs1518111 and rs3021094, as markers revealing the genetic association of IL10 in Koreans. This is the first report on the association of IL10 with OIs in HIV-infected Korean patients in the era of HAART. (Ann Clin Microbiol 2019;22:-22)
Abstract
Background: Genetic variants and haplotypes of the interleukin-10 (IL10) gene have been shown to affect clinical outcomes, including the incidence of opportunistic infections (OIs), in HIV-infected patients. This study investigated the effect of IL10 gene variants on susceptibility to OIs in HIV-infected Korean patients in the era of highly active antiretroviral therapy (HAART). Methods: Eighty-five HIV-infected patients receiving HAART were enrolled in the study. OIs were diagnosed based on the published criteria of the Korean Society for AIDS. Three promoter SNPs and four haplotype-tagging SNPs (htSNPs) of IL10 were selected and genotyped. The haplotypes were reconstructed according to the genotyping data and linkage disequilibrium (LD) status of these SNPs. Results: During the study, 38 OIs developed in 23 of the 85 patients (27.1%), at a rate of 1.7 episodes/ patient. Carrying the minor alleles at the rs1518111, rs3024490, and rs1800871 SNPs had a protective effect against OIs (adjusted P=0.035). Among the seven assessed variants, only three possible haplotypes were observed. The second most common haplotype, which was composed of the rs1518111 minor allele and the rs3021094 major allele showed a protective effect against OIs (P=0.0153). Conclusion: This study demonstrated that some IL10 genetic variants and haplotypes are associated with protective effects against OIs in the era of HAART. These data suggest the potential of two htSNPs, rs1518111 and rs3021094, as markers revealing the genetic association of IL10 in Koreans. This is the first report on the association of IL10 with OIs in HIV-infected Korean patients in the era of HAART. (Ann Clin Microbiol 2019;22:-22)
참고문헌 (26)
- Sterne JA, "Long-term effectiveness of potent antiretroviral therapy in preventing AIDS and death : a prospective cohort study", Lancet, 366, pp.378~384 (2005)
- Zanoni BC, "Update on opportunistic infections in the era of effective antiretroviral therapy", Infect Dis Clin North Am, 28, pp.501~518 (2014)
- Global Update on HIV Treatment 2013: Results, Impact and Opportunities, "WHO", WHO Press, ~ (2013)
- Manosuthi W, "Incidence and risk factors of major opportunistic infections after initiation of antiretroviral therapy among advanced HIV-infected patients in a resource-limited setting", J Infect, 55, pp.464~469 (2007)
- 김윤정, "Opportunistic diseases among HIV-infected patients: a multicenter-nationwide Korean HIV", AIDS cohort study, 2006 to 2013, 2016, pp.31(5), 953~960[DOI]
- Mocroft A, "The incidence of AIDS-defining illnesses at a current CD4count ≥200 cells", μL in the post-combination antiretroviral therapy era, 2013, pp.57, 1038~1047
- Naicker DD, "Association of IL-10-promoter genetic variants with the rate of CD4 T-cell loss, IL-10 plasma levels, andbreadth of cytotoxic T-cell lymphocyte response during chronic HIV-1 infection", Clin Infect Dis, 54, pp.294~302 (2012)
- Shrestha S, "Interleukin-10 (IL-10) pathway: genetic variants and outcomes of HIV-1 infection in African American adolescents", PLoS One, 5, pp.e13384~ (2010)
- Oleksyk TK, "Extended IL10 haplotypes and their association with HIV progression to AIDS", Genes Immun, 10, pp.309~322 (2009)
- Erikstrup C, "Reduced mortality and CD4cell loss among carriers of the interleukin-10 -1082G allele in a Zimbabwean cohort of HIV-1-infected adults", AIDS, 21, pp.2283~2291 (2007)
- Wang C, "Cytokine and chemokine gene polymorphisms among ethnically diverse North Americans with HIV-1 infection", J Acquir Immune Defic Syndr, 35, pp.446~454 (2004)
- Shin HD, "Genetic restriction of HIV-1 pathogenesis to AIDS by promoter alleles of IL10", Proc Natl Acad Sci U S A, 97, pp.14467~14472 (2000)
- Moore KW, "Interleukin-10 and the interleukin-10 receptor", Annu Rev Immunol, 19, pp.683~765 (2001)
- Ho AS, "Interleukin-10 and its receptor", Ther Immunol, 1, pp.173~185 (1994)
- 위성헌, "The 2013 Clinical Guidelines for the Diagnosis and Treatment of HIV", AIDS in HIV-Infected Koreans, 2013, pp.45(4), 455~461[DOI]
- Kingkeow D, "Frequencies of IL10 SNP genotypes by multiplex PCR-SSP and their association with viral load and CD4 counts in HIV-1-infected Thais", Asian Pac J Allergy Immunol, 29, pp.94~101 (2011)
- Smolnikova MV, "Association of IL2, TNFA, IL4 and IL10 promoter gene polymorphisms with the rate of progression of the HIV infection", Russ J Immunol, 7, pp.349~356 (2002)
- Gabriel SB, "The structure of haplotype blocks in the human genome", Science, 296, pp.2225~2229 (2002)
- International HapMap Consortium, "The International HapMap Project", Nature, 426, pp.789~796 (2003)
- Jurinke C, "Automated genotyping using the DNA MassArray technology", Methods Mol Biol, 187, pp.179~192 (2002)
- Phillips MS, "Chromosome-wide distribution of haplotype blocks and the role of recombination hot spots", Nat Genet, 33, pp.382~387 (2003)
- Barrett JC, "Haploview : analysis and visualization of LD and haplotype maps", Bioinformatics, 21, pp.263~265 (2005)
- Remmers EF, "Genome-wide association study identifies variants in the MHC class I, IL10, and IL23R-IL12RB2 regions associated with Behçet's disease", Nat Genet, 42, pp.698~702 (2010)
- Vasilescu A, "Genomic analysis of Th1-Th2 cytokine genes in an AIDS cohort : identification of IL4 and IL10 haplotypes associated with the disease progression", Genes Immun, 4, pp.441~449 (2003)
- Wohl AR, "Risk of opportunistic infection in the HAART era among HIV-infected Latinos born in the United States compared to Latinos born in Mexico and Central America", AIDS Patient Care STDS, 17, pp.267~275 (2003)
- WHO, "Consolidated Guidelines on the Use of Antiretroviral Drugs for Treating and Preventing HIV Infection", WHO press, ~ (2013)